Date: Apr 27, 2021 (Tuesday)
Time: 12:30 p.m. - 1:30 p.m. HKT (GMT+8)
[Virtual waiting room will start at 12:20 pm]
Please log in the webinar link 10 mins in advance of the session start time to allow some time to solve the technical issues (if any) and the webinar will start promptly at 12:30 pm.
With the effect of Chapter 18A of the HKEX Listing Rules and the rising trend of overseas students returning back to China to start businesses, a large number of unprofitable healthcare start-ups have come to list on the Hong Kong Stock Exchange. In recent years, these high-valued and high-growth companies have become hot spots.
There are many sub-sectors within healthcare industry, including pharmaceuticals, biotech, distributions, CRO/CDMO, medical equipment, etc.
Due to the uniqueness of business, healthcare companies have their own characteristics of valuation methods. DCF plus pipeline or multiples comparison are two most commonly used valuation method for healthcare industry.
Since the beginning of 2021, given the uncertainty of external macro environment (such as mass vaccination, economic recovery expectations, inflation expectations, shrinking balance sheet expectations, etc.), the valuation of healthcare sector has fluctuated significantly. To learn more about the potential healthcare investing opportunities based on fundamental research, welcome to join us on the coming seminar.
This webinar qualifies for 1 CPT/CE/RBV/CPD hour.
To qualify for CPT/CE hours, participants must attend the full webinar.